Auth bypass in Medtronic Insterstim Applications
CVE-2023-25931
Medtronic identified that the Pelvic Health clinician apps, which are installed on the Smart Programmer mobile device, have a password vulnerability that requires a security update to fix. Not updating could potentially result in unauthorized control of the clinician therapy application, which has greater control over therapy parameters than the patient app. Changes still cannot be made outside of the established therapy parameters of the programmer. For unauthorized access to occur, an individual would need physical access to the Smart Programmer.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.4 (Medium). Vector: CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H.
EPSS exploit prediction
EPSS: 0.003 (16.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 17th percentile — 16.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.003 · newest: 0.003 · change: 0.000
Affected products
- Medtronic Insterstim Applications — versions Micro Clinician, InterStim X Clinician
- Medtronic Interstim X Clinician — versions a51300
- Medtronic Micro Clinician — versions a51200
Weakness classification (CWE)
References
Frequently asked questions
- What is CVE-2023-25931?
- CVE-2023-25931 is a medium-severity vulnerability in Medtronic Insterstim Applications, classified under CWE-620. CVSS score: 6.4/10. Published 2023-03-01.
- How severe is CVE-2023-25931?
- Medium severity. CVSS v3 base score is 6.4 out of 10.